Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI

Investigator ID 1001, Brussels

Investigator ID 1002, Brussels

Investigator ID 1003, Brussels

Investigator ID 1004, Brussels

Investigator ID 1107, Olomouc

Investigator ID 1101, Prague

Investigator ID 1102, Prague

Investigator ID 1103, Prague

Investigator ID 1104, Prague

Investigator ID 1108, Prague

Investigator ID 1109, Teplice

Investigator ID 1106, Zlín

Investigator ID 1204, Copenhagen

Investigator ID 1205, Herlev

Investigator ID 1202, Hvidovre

Investigator ID 1203, Skive

Investigator ID 1301, Tartu

Investigator ID 1303, Tartu

Investigator ID 1401, Helsinki

Investigator ID 1402, Helsinki

Investigator ID 1403, Oulu

Investigator ID 1501, Heidelberg

Investigator ID 1502, Lübeck

Investigator ID 1504, Mainz

Investigator ID 1503, Marburg

Investigator ID 1601, Budapest

Investigator ID 1604, Budapest

Investigator ID 1603, Pécs

Investigator ID 1602, Tapolca

Investigator ID 1701, Bialystok

Investigator ID 1703, Bialystok

Investigator ID 1705, Bialystok

Investigator ID 1702, Katowice

Investigator ID 1704, Szczecin

Investigator ID 1706, Warsaw

Investigator ID 1801, Barakaldo

Investigator ID 1805, Barcelona

Investigator ID 1808, Barcelona

Investigator ID 1809, Leioa

Investigator ID 1804, Madrid

Investigator ID 1807, Madrid

Investigator ID 1811, Seville

Investigator ID 1806, Valencia